Share price & information

OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris

  • ISIN: FR0012127173
  • Ticker: OSE
  • Type of listing: continuous
  • Number of outstanding shares: 14,374,970 shares and voting rights as of June 30, 2017
  • Eligible to Long-Only Deferred Settlement Service

Click here for
live stock price

Analysts following OSE Immunotherapeutics

  • H.C. Wainwright & CO.
    – Swayampakula Ramakanth, Ph.D. – 212-356-0544 – sramakanth@hcwresearch.com
    – Sean Lee – 212-356-0521 – slee@hcwresearch.com
  • LifeSci Capital – Initiation Report (27 February 2017)
  • Kepler Cheuvreux : Thomas Guillot – Initiation note (20 February 2017)
  • Portzamparc : Ricky Bhajun, Arnaud Guérin – Initiation of coverage note (6 July 2016)
  • CM CIC Securities: Arsène Guékam – Initiation of coverage note (8 July 2015)
  • Aurgalys: Jamila El Bougrini, Mickael Dubourd  – Initiation Report (24  June 2015)
  • Invest Securities: Daniel Anizon, Martial Descoutures Initiation of coverage note (29 May 2015)

Analyst Reports

27 June 2017: Aurgalys
13 June 2017 : LifeSci Capital  – Company Update
24 May 2017: Aurgalys
4 January 2017 : Aurgalys
22 November 2016 : Aurgalys
12 October 2016 – Portzamparc
5 July 2016 – Aurgalys
7 June 2016 – Aurgalys
16 March 2016 – Aurgalys
10 February 2016 –
Aurgalys

* 11 November 2015 –
Aurgalys

Ownership as of December 31, 2016

Sign up to receive press releases by email.

Subscribe to our newsletter

Select one or more lists: